Development of proteomic signatures of platelet activation using surface-enhanced laser desorption/ionization technology in a clinical setting.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Clinical Pathology

• Publication date

  2008-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1309/BC0RXR50KKKWCVHMPMID 18480001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic analysis of platelet alpha-granules using mass spectrometry.

  2007cited by this paper
• Proteomic analysis of platelet α‐granules using mass spectrometry

  2007cited by this paper
• P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents.

  2006cited by this paper
• SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occuring before age 40

  2006cited by this paper
• Platelet genomics and proteomics in human health and disease.

  2005cited by this paper
• Applying proteomics technology to platelet research.

  2005cited by this paper
• Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee

  2005cited by this paper
• Distinct proteome features of plasma microparticles

  2005cited by this paper
• Proteomic profiling of mature CD10+ B-cell lymphomas.

  2005cited by this paper
• The platelet microparticle proteome.

  2005cited by this paper
• Using proteomics to identify potential therapeutic targets in platelets.

  2005cited by this paper
• Mass Spectrometry in Diagnostic Oncoproteomics

  2005cited by this paper
• Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy

  2005cited by this paper
• Analyzing the platelet proteome.

  2004cited by this paper
• Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins.

  2004cited by this paper
• Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.

  2004cited by this paper
• Integration of Proteomics and Genomics in Platelets

  2004cited by this paper
• SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers

  2004cited by this paper
• Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

  2004cited by this paper
• Application of proteomics to the study of platelet regulatory mechanisms.

  2004cited by this paper
• Two-dimensional polyacrylamide gel electrophoresis for platelet proteomics.

  2004cited by this paper
• Extensive analysis of the human platelet proteome by two‐dimensional gel electrophoresis and mass spectrometry

  2004cited by this paper
• Platelet proteomics

  2003cited by this paper
• Correspondence re: B-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.

  2003cited by this paper
• From genomics to proteomics

  2003cited by this paper
• Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction.

  2003cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• The laboratory evaluation of platelet dysfunction.

  2002cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

  2002cited by this paper
• Towards complete analysis of the platelet proteome

  2002cited by this paper
• Identification of the phosphotyrosine proteome from thrombin activated platelets

  2002cited by this paper
• SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.

  2002cited by this paper
• A fast and convenient MALDI-MS based proteomic approach: identification of components scaffolded by the actin cytoskeleton of activated human thrombocytes.

  2000cited by this paper
• Identification of phosphorylated proteins from thrombin‐activated human platelets isolated by two‐dimensional gel electrophoresis by electrospray ionization‐tandem mass spectrometry (ESI‐MS/MS) and liquid chromatography‐electrospray ionization‐mass spectrometry (LC‐ESI‐MS)

  1998cited by this paper
• A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions.

  1997cited by this paper
• Platelets and shear stress.

  1996cited by this paper
• Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

  1993cited by this paper
• Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.

  1991cited by this paper
• Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.

  1985cited by this paper

• The integration of proteomics and systems approaches to map regulatory mechanisms underpinning platelet function

  2013cites this paper
• Protéomique et médecine transfusionnelle

  2011cites this paper
• Proteomics of blood and derived products: what’s next?

  2011cites this paper
• [Proteomics and transfusion medicine].

  2011cites this paper
• Proteomic and Metabolomic Profiles in Atherothrombotic Vascular Disease

  2010cites this paper
• Contents

  2009cites this paper
• Challenges, current status and future perspectives of proteomics in improving understanding, diagnosis and treatment of vascular disease.

  2009cites this paper